Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Aigner

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
EMBO Molecular Medicine|July 16, 2013
Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescenceVeronika Hampl, Claudia Martin, Achim Aigner, et al.
Neoplasia (New York, N.Y.)|January 26, 2025
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostatTamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Cancer Research|December 18, 2003
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesisRanjan Ray, Rafael Cabal-Manzano, Amy R Moser, et al.
Medchemcomm|August 9, 2019
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activityNina Reßing, Viktoria Marquardt, Christoph G W Gertzen, et al.
Acta Biomaterialia|March 25, 2014
Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapyGeorge R Dakwar, Elisa Zagato, Joris Delanghe, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2007
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cellsJudith von Haussen, Rembert Koczulla, Renat Shaykhiev, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2023
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumorsVivien Topf, Yuri Kheifetz, Severin Daum, et al.
Biochemical Pharmacology|May 5, 2024
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancerRobert Jenke, Denys Oliinyk, Tamara Zenz, et al.
Nutrients|August 29, 2024
The Concentration of Salivary Extracellular Vesicles Is Related to ObesityKristin Röhrborn, Martin Krueger, Mirjam Kalusa, et al.
Current Gene Therapy|February 18, 2015
Tau silencing by siRNA in the P301S mouse model of tauopathyHong Xu, Thomas W Rösler, Thomas Carlsson, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
EMBO Molecular Medicine|July 16, 2013
Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescenceVeronika Hampl, Claudia Martin, Achim Aigner, et al.
Neoplasia (New York, N.Y.)|January 26, 2025
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostatTamara Zenz, Robert Jenke, Denys Oliinyk, et al.
Cancer Research|December 18, 2003
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesisRanjan Ray, Rafael Cabal-Manzano, Amy R Moser, et al.
Medchemcomm|August 9, 2019
Design, synthesis and biological evaluation of β-peptoid-capped HDAC inhibitors with anti-neuroblastoma and anti-glioblastoma activityNina Reßing, Viktoria Marquardt, Christoph G W Gertzen, et al.
Acta Biomaterialia|March 25, 2014
Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapyGeorge R Dakwar, Elisa Zagato, Joris Delanghe, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2007
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cellsJudith von Haussen, Rembert Koczulla, Renat Shaykhiev, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2023
Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumorsVivien Topf, Yuri Kheifetz, Severin Daum, et al.
Biochemical Pharmacology|May 5, 2024
HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancerRobert Jenke, Denys Oliinyk, Tamara Zenz, et al.
Nutrients|August 29, 2024
The Concentration of Salivary Extracellular Vesicles Is Related to ObesityKristin Röhrborn, Martin Krueger, Mirjam Kalusa, et al.
Current Gene Therapy|February 18, 2015
Tau silencing by siRNA in the P301S mouse model of tauopathyHong Xu, Thomas W Rösler, Thomas Carlsson, et al.
Pageof 18